Sfoglia per Titolo
Oxygen vacancy: the invisible agent on oxide surfaces
2003 Pacchioni, G
OXYGEN-CHEMISORPTION BY GAMMA-AL2O3 PHTHALOCYANINATO COBALT(II) - INFLUENCE OF THE SURFACE SPECIES GAMMA-AL2O3 ON O-2(-) FIXATION
1979 Mercati, G; Morazzoni, F; Barzaghi, M; Carniti, P; Ragaini, V; Campadelli, F
OXYGEN-CHEMISORPTION ON GAMMA-AL2O3.PHTHALOCYANINATO-COBALT(II) - COORDINATION OF O-2 BY COMPLEXED COBALT CENTERS - TUMBLING OF MOLECULAR-OXYGEN ON SURFACE COBALT CENTERS
1982 Barzaghi, M; Beringhelli, T; Morazzoni, F
Oxygen-deficiency effect on thermal poling of silica-based glasses
2005 Franchina, E; Corbari, C; Kazansky, P; Chiodini, N; Lauria, A; Paleari, A
Oxygen-enhanced Extremely Metal-poor Damped Ly-alpha Systems: A Signpost of the First Stars?
2022 Welsh, L; Cooke, R; Fumagalli, M; Pettini, M
Oxygen-Induced Transformations of an FeO(111) Film on Pt(111): A Combined DFT and STM Study
2010 Giordano, L; Lewandowski, M; Groot, I; Sun, Y; Goniakowski, J; Noguera, C; Shaikhutdinov, S; Pacchioni, G; Freund, H
Oxygen-loaded nanodroplets effectively abrogate hypoxia dysregulating effects on secretion of MMP-9 and TIMP-1 by human monocytes
2015 Gulino, G; Magnetto, C; Khadjavi, A; Panariti, A; Rivolta, I; Soster, M; Argenziano, M; Cavalli, R; Giribaldi, G; Guiot, C; Prato, M
Oxygenation derangements after subarachnoid hemorrhage: incidence and impact on the outcome. Data from a large multicenter, retrospective study
2019 Citerio, G; Mazeraud, A; Robba, C; Iaquaniello, C; Rebora, P; Vargiolu, A; Rass, V; Bogossian, E; Helbok, R; Taccone, F
Oxysterols and Alzheimer's disease
2006 Björkhem, I; Heverin, M; Leoni, V; Meaney, S; Diczfalusy, U
Oxysterols and cholesterol metabolism in neurodegenerative disease. A metabolic approach
2011 Leoni, V; Caccia, C; Tiranti, V
Oxysterols and multiple sclerosis: Physiopathology, evolutive biomarkers and therapeutic strategy
2021 Vejux, A; Ghzaiel, I; Nury, T; Schneider, V; Charriere, K; Sghaier, R; Zarrouk, A; Leoni, V; Moreau, T; Lizard, G
Oxysterols and neurodegenerative diseases
2009 Björkhem, I; Cedazo-Minguez, A; Leoni, V; Meaney, S
Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
2013 Björkhem, I; Lövgren-Sandblom, A; Leoni, V; Meaney, S; Brodin, L; Salveson, L; Winge, K; Pålhagen, S; Svenningsson, P
Oxysterols as biomarkers in neurodegenerative diseases
2011 Leoni, V; Caccia, C
Oxysterols as markers of neurological disease--a review
2009 Leoni, V
Oxysterols as Reliable Markers of Quality and Safety in Cholesterol Containing Food Ingredients and Products
2022 Canzoneri, F; Leoni, V; Rosso, G; Risso, D; Menta, R; Poli, G
Oxysterols in bile acid metabolism
2011 Crosignani, A; Zuin, M; Allocca, M; DEL PUPPO, M
Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2
2021 Staurenghi, E; Cerrato, V; Gamba, P; Testa, G; Giannelli, S; Leoni, V; Caccia, C; Buffo, A; Noble, W; Perez-Nievas, B; Leonarduzzi, G
Oxysterols: From redox bench to industry
2022 Poli, G; Leoni, V; Biasi, F; Canzoneri, F; Risso, D; Menta, R
Oxytocin and Facial Expressivity in Patients with Schizophrenia and Healthy Participants
2013 Woolley, J; Fussell, C; Lai, W; Lam, O; Chuang, B; Biagianti, B; Fulford, D; Mathalon, D; Vinogradov, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile